Specific genotypes of human papillomavirus in 125 high-grade squamous lesions and invasive cervical cancer cases from Congolese women

被引:11
|
作者
Boumba, Luc Magloire Anicet [1 ,2 ,3 ]
Hilali, Lahoucine [2 ]
Mouallif, Mustapha [1 ,4 ]
Moukassa, Donatien [3 ]
Ennaji, Moulay Mustapha [1 ]
机构
[1] Univ Hassan II Mohammedia, Fac Sci & Tech, Lab Virol Microbiol & Qual ETB, BP 146, Mohammadia 20650, Morocco
[2] Univ Hassan, Fac Sci & Tech, Dept Biol Appl, Lab Agroalimentaire & Sante, Settat, Morocco
[3] Hop Gen Loandjili, Lab Anal Med & Morphol, Pointe Noire, Rep Congo
[4] Univ Hassan, Inst Super Sci Sante, Settat, Morocco
关键词
Specific-genotype; HPV; HSIL; ICC; Southwestern Congo; PARTICLE VACCINE; HPV; PREVALENCE; RISK; POPULATION; INFECTION; TYPE-18; PERSISTENCE; WORLDWIDE; EFFICACY;
D O I
10.1186/1471-2458-14-1320
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Knowledge on HPV prevalence and genotype distribution in HSIL and ICC is highly essential for the introduction of an effective vaccination program and appropriate epidemiological monitoring of viral ecology before and after vaccination in Congo. This study aimed to determine the specific-HPV genotypes in HSIL and ICC among women in southwestern Congo. Methods: 125 archival paraffin-embedded biopsy collected between 2008 and 2012 and histologically diagnosed were investigated. DNA extraction was performed using the phenol/chloroform method. HPV search was performed by nested-PCR using MY09/MY11 and GP5+/GP6+ consensus primers followed by direct sequencing. Results: The mean age of participants was 44.3 +/- 8.2 years. Overall, HPV prevalence was 89.6% (112/125) with all high-risk genotypes. HPV DNA was detected in 81.5% (53/65) of HSIL and 98.3% (59/60) of ICC. HPV 16 the most common genotype was detected in 47.1% (25/53) of HSIL and 52.5% (31/59) of ICC. Other types identified were: HPV 33 (22.6%), HPV 18 (15%), HPV 31 (11.3%) and HPV 69 (3.7%) in HSIL, and HPV 33 (28.8%), HPV 18 (11.8%), HPV 31 (5%) and HPV 35 (1.7%) in ICC. Knowing that the ADC accounted for 6.7% (4/60) of ICC cases, HPV 18 was identified in 25% (1/4) of these cases against 75% (3/4) for HPV 16. Conclusion: Our study showed that HPV 16, 33, 18 and 31 were the four most common genotypes in women with HSIL and ICC. These findings indicate that current vaccines against HPV could help to reduce the burden of cervical cancer in Congo.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women
    C Clavel
    M Masure
    J-P Bory
    I Putaud
    C Mangeonjean
    M Lorenzato
    P Nazeyrollas
    R Gabriel
    C Quereux
    P Birembaut
    British Journal of Cancer, 2001, 84 : 1616 - 1623
  • [42] Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women
    Clavel, C
    Masure, L
    Bory, JP
    Putaud, I
    Mangeonjean, C
    Lorenzato, M
    Nazeyrollas, P
    Gabriel, R
    Quereux, C
    Birembaut, P
    BRITISH JOURNAL OF CANCER, 2001, 84 (12) : 1616 - 1623
  • [43] Human papillomavirus-induced lesions of the anogenital tract among women with vulvar high-grade squamous intraepithelial lesions
    Isnard, Camille
    Seta, Vannina
    Cesbron, Elise
    Bergeron, Christine
    Chanal, Johan
    Aynaud, Olivier
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (06) : 1749 - 1750
  • [44] Human papillomavirus vaccination is changing the epidemiology of high-grade cervical lesions in Australia
    Brotherton, Julia M. L.
    Saville, A. Marion
    May, Cathryn L.
    Chappell, Genevieve
    Gertig, Dorota M.
    CANCER CAUSES & CONTROL, 2015, 26 (06) : 953 - 954
  • [45] Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
    Villa, Luisa L.
    Perez, Gonzalo
    Kjaer, Susanne K.
    Paavonen, Jorma
    Lehtinen, Matti
    Munoz, Nubia
    Sigurdsson, Kristjan
    Hernandez-Avila, Mauricio
    Skjeldestad, Finn Egil
    Thoresen, Steinar
    Garcia, Patricia
    Majewski, Slawomir
    Dillner, Joakim
    Olsson, Sven-Eric
    Tay, Eng Hseon
    Bosch, F. Xavier
    Ault, Kevin A.
    Brown, Darron R.
    Ferris, Daron G.
    Koutsky, Laura A.
    Kurman, Robert J.
    Myers, Evan R.
    Barr, Eliav
    Boslego, John
    Bryan, Janine
    Esser, Mark T.
    Gause, Christine K.
    Hesley, Teresa M.
    Lupinacci, Lisa C.
    Sings, Heather L.
    Taddeo, Frank J.
    Thornton, Annemarie R.
    Boulos, M.
    Cox, J. T.
    Langmark, F.
    Modlin, J.
    Munoz, A.
    Odlind, V.
    Wilkinson, E.
    Ferenczy, A.
    Kurman, R.
    Ronett, B.
    Stoler, M.
    Andreoni, G.
    Bahamondes, L.
    Camargos, A.
    Costa, R.
    De Andrade, R.
    Fedrizzi, E.
    Ferriani, R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19): : 1915 - 1927
  • [46] Human papillomavirus vaccination is changing the epidemiology of high-grade cervical lesions in Australia
    Julia M. L. Brotherton
    A. Marion Saville
    Cathryn L. May
    Genevieve Chappell
    Dorota M. Gertig
    Cancer Causes & Control, 2015, 26 : 953 - 954
  • [47] Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections
    Hawes, SE
    Critchlow, CW
    Niang, MAF
    Diouf, MB
    Diop, A
    Touré, P
    Kasse, AA
    Dembele, B
    Sow, PS
    Coll-Seck, AM
    Kuypers, JM
    Kiviat, NB
    JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (04): : 555 - 563
  • [48] Effect of smoking on high-grade cervical cancer in women on the basis of human papillomavirus infection studies
    Fang, Jian-Hong
    Yu, Xue-Mei
    Zhang, Shu-Hong
    Yang, Yan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S184 - S189
  • [49] Cervical screening, high-grade squamous lesions, and cervical cancer in illicit drug users
    Kricker, Anne
    Burns, Lucinda
    Goumas, Chris
    Armstrong, Bruce K.
    CANCER CAUSES & CONTROL, 2013, 24 (07) : 1449 - 1457
  • [50] Cervical screening, high-grade squamous lesions, and cervical cancer in illicit drug users
    Anne Kricker
    Lucinda Burns
    Chris Goumas
    Bruce K. Armstrong
    Cancer Causes & Control, 2013, 24 : 1449 - 1457